nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Ageusia—Cisplatin—peripheral nervous system neoplasm	0.0212	0.0212	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Tretinoin—peripheral nervous system neoplasm	0.0168	0.0168	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Isotretinoin—peripheral nervous system neoplasm	0.0168	0.0168	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.0149	0.0149	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.0149	0.0149	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Alitretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Methylscopolamine bromide—Tension—Tretinoin—peripheral nervous system neoplasm	0.0114	0.0114	CcSEcCtD
Methylscopolamine bromide—Tension—Isotretinoin—peripheral nervous system neoplasm	0.0114	0.0114	CcSEcCtD
Methylscopolamine bromide—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Methylscopolamine bromide—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.0112	0.0112	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.011	0.011	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.011	0.011	CcSEcCtD
Methylscopolamine bromide—Ageusia—Epirubicin—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Methylscopolamine bromide—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Methylscopolamine bromide—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Methylscopolamine bromide—Ageusia—Doxorubicin—peripheral nervous system neoplasm	0.0101	0.0101	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00969	0.00969	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00969	0.00969	CcSEcCtD
Methylscopolamine bromide—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00957	0.00957	CcSEcCtD
Methylscopolamine bromide—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00957	0.00957	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00957	0.00957	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00949	0.00949	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00949	0.00949	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00937	0.00937	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00927	0.00927	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00927	0.00927	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00915	0.00915	CcSEcCtD
Methylscopolamine bromide—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00865	0.00865	CcSEcCtD
Methylscopolamine bromide—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Methylscopolamine bromide—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Methylscopolamine bromide—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00856	0.00856	CcSEcCtD
Methylscopolamine bromide—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00844	0.00844	CcSEcCtD
Methylscopolamine bromide—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00844	0.00844	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00831	0.00831	CcSEcCtD
Methylscopolamine bromide—Constipation—Topotecan—peripheral nervous system neoplasm	0.00818	0.00818	CcSEcCtD
Methylscopolamine bromide—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00812	0.00812	CcSEcCtD
Methylscopolamine bromide—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00812	0.00812	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00789	0.00789	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00782	0.00782	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00782	0.00782	CcSEcCtD
Methylscopolamine bromide—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00779	0.00779	CcSEcCtD
Methylscopolamine bromide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.0076	0.0076	CcSEcCtD
Methylscopolamine bromide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00754	0.00754	CcSEcCtD
Methylscopolamine bromide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00754	0.00754	CcSEcCtD
Methylscopolamine bromide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00744	0.00744	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00734	0.00734	CcSEcCtD
Methylscopolamine bromide—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00725	0.00725	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00719	0.00719	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00708	0.00708	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00705	0.00705	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00702	0.00702	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00699	0.00699	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00699	0.00699	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00693	0.00693	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0069	0.0069	CcSEcCtD
Methylscopolamine bromide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00687	0.00687	CcSEcCtD
Methylscopolamine bromide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00681	0.00681	CcSEcCtD
Methylscopolamine bromide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00681	0.00681	CcSEcCtD
Methylscopolamine bromide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00672	0.00672	CcSEcCtD
Methylscopolamine bromide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Methylscopolamine bromide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0064	0.0064	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00639	0.00639	CcSEcCtD
Methylscopolamine bromide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00633	0.00633	CcSEcCtD
Methylscopolamine bromide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00628	0.00628	CcSEcCtD
Methylscopolamine bromide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00628	0.00628	CcSEcCtD
Methylscopolamine bromide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00627	0.00627	CcSEcCtD
Methylscopolamine bromide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00615	0.00615	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00613	0.00613	CcSEcCtD
Methylscopolamine bromide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00608	0.00608	CcSEcCtD
Methylscopolamine bromide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00604	0.00604	CcSEcCtD
Methylscopolamine bromide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00604	0.00604	CcSEcCtD
Methylscopolamine bromide—Headache—Topotecan—peripheral nervous system neoplasm	0.006	0.006	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00598	0.00598	CcSEcCtD
Methylscopolamine bromide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00596	0.00596	CcSEcCtD
Methylscopolamine bromide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00595	0.00595	CcSEcCtD
Methylscopolamine bromide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00595	0.00595	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00593	0.00593	CcSEcCtD
Methylscopolamine bromide—Constipation—Vincristine—peripheral nervous system neoplasm	0.00593	0.00593	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Methylscopolamine bromide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Methylscopolamine bromide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00568	0.00568	CcSEcCtD
Methylscopolamine bromide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00566	0.00566	CcSEcCtD
Methylscopolamine bromide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00564	0.00564	CcSEcCtD
Methylscopolamine bromide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00564	0.00564	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00562	0.00562	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Methylscopolamine bromide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00548	0.00548	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0053	0.0053	CcSEcCtD
Methylscopolamine bromide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00516	0.00516	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00516	0.00516	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00511	0.00511	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Methylscopolamine bromide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00499	0.00499	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00497	0.00497	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00494	0.00494	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00493	0.00493	CcSEcCtD
Methylscopolamine bromide—Constipation—Etoposide—peripheral nervous system neoplasm	0.0048	0.0048	CcSEcCtD
Methylscopolamine bromide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00476	0.00476	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Methylscopolamine bromide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00458	0.00458	CcSEcCtD
Methylscopolamine bromide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00452	0.00452	CcSEcCtD
Methylscopolamine bromide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Methylscopolamine bromide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00446	0.00446	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00441	0.00441	CcSEcCtD
Methylscopolamine bromide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.0044	0.0044	CcSEcCtD
Methylscopolamine bromide—Headache—Vincristine—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Methylscopolamine bromide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00414	0.00414	CcSEcCtD
Methylscopolamine bromide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Methylscopolamine bromide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Methylscopolamine bromide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0039	0.0039	CcSEcCtD
Methylscopolamine bromide—Tension—Epirubicin—peripheral nervous system neoplasm	0.00379	0.00379	CcSEcCtD
Methylscopolamine bromide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Methylscopolamine bromide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Methylscopolamine bromide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00364	0.00364	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00364	0.00364	CcSEcCtD
Methylscopolamine bromide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Methylscopolamine bromide—Headache—Etoposide—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Methylscopolamine bromide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Methylscopolamine bromide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00347	0.00347	CcSEcCtD
Methylscopolamine bromide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Methylscopolamine bromide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Methylscopolamine bromide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Methylscopolamine bromide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Methylscopolamine bromide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Methylscopolamine bromide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Methylscopolamine bromide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Methylscopolamine bromide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Methylscopolamine bromide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Methylscopolamine bromide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Methylscopolamine bromide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Methylscopolamine bromide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Methylscopolamine bromide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Methylscopolamine bromide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Methylscopolamine bromide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Methylscopolamine bromide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Methylscopolamine bromide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Methylscopolamine bromide—Headache—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Methylscopolamine bromide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Methylscopolamine bromide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Methylscopolamine bromide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Methylscopolamine bromide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Methylscopolamine bromide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
